Corona Single Dose Vaccine : Single dose vaccine of Johnson & Johnson will be available in the country by the end of this year. On Wednesday, Paul Stoffels, the Chief Scientific Officer of this American company, gave this information. The Indian government last month approved Johnson & Johnson’s single-dose vaccine for emergency use. In India, apart from only Kovidshield, Johnson & Johnson’s vaccine has got approval from the World Health Organization (WHO). Because of this, there is a lot of curiosity in the country about Johnson & Johnson’s single dose vaccine.
Biological E Ltd to manufacture single dose vaccine in India
Its local partner company in Johnson & Johnson’s vaccines will be made by Biological E Ltd. On behalf of the company, it has been said that it is finalizing the manufacture of the vaccine at its manufacturing plant. It is validating the vaccine here. Around the world 700 million doses of Johnson & Johnson have been given. This will be the fifth vaccine to be available in the country. Earlier, Bharat Biotech’s vaccine Covaccine, Serum Institute’s Covishield, Russian Sputnik and Zydus Cadila’s Zycov-D are being found in India.
Maruti Suzuki Production Dip: Chip shortage added to the problem, production decreased by 8% in August, this month only 40% of vehicles will be made
Fear of third wave increased importance of single dose vaccine
In a press conference organized by the International Federation of Pharmaceutical Companies (IFPMA), Paul Stoffels said that we are transferring our technology to biological e in India. We hope that 50 percent of our vaccine will soon be available to low and middle income countries. With the growing fear of a third wave of corona and the emergence of Delta and Mu variants, the need to make new vaccines available at the earliest has increased significantly. Especially in such a situation, the usefulness of single dose vaccine has increased a lot.